Immunovant, Inc. (IMVT)
29.10
+0.72
(+2.54%)
USD |
NASDAQ |
Oct 22, 16:00
29.12
+0.02
(+0.07%)
After-Hours: 20:00
Immunovant Gross Profit Margin (Quarterly)
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Roivant Sciences Ltd. | 38.70% |
| Moderna, Inc. | -7.59% |
| Altimmune, Inc. | -- |
| Vertex Pharmaceuticals, Inc. | 85.37% |
| First Tracks Biotherapeutics, Inc. | -- |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -72.69% |
| Return on Assets | -65.53% |
| Return on Invested Capital | -72.68% |
| Return on Net Operating Assets | -26.53K% |